Come visit poster 0138 in the poster hall where Dr Kevin Harkin, our Head of Ophthalmology, will be presenting data on
‘Unmasking EMT: A fibrotic Package Linking scRNA-seq insights to ARPE-19 functional assays’
#ARVO2026#denver#fibrosis#AMD
🧫 We’re developing a new 3D model to better replicate human biology without using animals.
🔬 This system supports drug discovery while advancing the 3Rs—especially Replacement.
🌱 Proud to push for more ethical, human-relevant science
#AnimalStats#3Rs#OpennessInAnimalResearch
🧬 At MediNect we work with biopharma to develop new drugs for people suffering from blindness
🐁 Animal models have been vital in advancing drug development
🔄 We continue to apply the 3Rs—Refine, Reduce, Replace—to minimise animal use
#AnimalStats#3Rs#OpennessInAnimalResearch
🔬Fantastic #ARVO2024 Day 1!
Such interest & great feedback on our subretinal fibrosis model presented by Dr Kevin Harkin, developed by the esteemed researchers @QUBelfast
Reach out to us to book a follow-up meeting here @ ARVO!
#AMD#partnering#new#preclinicalCRO
🔬Excited for #ARVO2024 Day 1!
Join us at Poster B0220 where Dr. Kevin Harkin will present our validation of the subretinal fibrosis model, an exciting model for fibrosis in nAMD. Visit from 13:00-14:45 to learn more. See you there! #VisionResearch#Preclinical#Collaboration
The countdown is on! One week from today, the MediNect team will be at #ARVO2024! Get in touch to meet us there to chat all things preclinical: https://t.co/5j4jhPdKPv
#ARVO#OphthalmologyResearch#PreclinicalCRO
Cancelled @Delta flight from Dublin yesterday. New flight booked to #NewOrleans with @AerLingus. Connecting flight in NYC cancelled with a 10 (ten) hour delay before cancellation. Running on empty and no sleep but we’re FINALLY on a flight to #NewOrleans. See you soon #ARVO2023
New #newsletter on @LinkedIn about preclinical in vivo models of #retinaldisease. Our first edition includes advantages/disadvantages of mouse models for #diabeticretinopathy. We offer these models & expert advice. Check it out!
https://t.co/A44X9dCPiX
Excited to attend the #ARVO2023 conference next week and connect with leading retinal disease researchers. As a preclinical CRO, I'm looking forward to engaging in insightful discussions and advancing our collective understanding of ocular diseases. #ophthalmology#research